Pediatric cardiac Extracorporeal Membrane Oxygenation (ECMO) is effective, however, bleeding and clotting issues continue to cause significant morbidity and mortality. The objective of this study was to assess the correlation between measures of anticoagulation, the heparin dose in pediatric cardiac ECMO patients as well as to assess covert coagulopathy as measured by thromboelastography (TEG).
Methods:
Retrospective study of cardiac ECMO patients in a large, academic referral center using anticoagulation data during the ECMO support.
Results:
Five hundred and eighty-four sets of anticoagulation tests and 343 TEG from 100 patients with median age of 26 days were reviewed. ECMO was post-surgical for congenital heart disease in 94% with resuscitation (ECPR) in 38% of the cases. Mean duration of support was 6.3 days. Overall survival to discharge was 35%. There was low but statistically significant correlation between individual anticoagulation measures and low correlation between Anti-Xa levels and heparin dose. There was no correlation between PTT and heparin dose. 343 TEG with Heparinase were reviewed to assess covert coagulopathy which was present in 25% of these. The coagulopathy noted was pro-hemorrhagic in almost all of the cases with high values of reaction time and kinetics and low values for angle and maximum amplitude.
Conclusion:
Coagulation monitoring on ECMO may benefit from addition of Heparinase TEG to diagnose covert coagulopathy which can contribute to significant hemorrhagic complications. There is a need for a prospective, thromboelastography guided intervention trial to reduce coagulopathy related morbidity and mortality in ECMO.
BartlettRH.Extracorporeal life support: history and new directions. ASAIO J2005; 51(5): 487–489.
2.
NasrVGRamanLBarbaroRP, et al. Highlights from the Extracorporeal Life Support Organization Registry: 2006–2017. ASAIO J2019; 65(6): 537–544.
3.
WerhoDKPasqualiSKYuS, et al. Hemorrhagic complications in pediatric cardiac patients on extracorporeal membrane oxygenation: an analysis of the Extracorporeal Life Support Organization Registry. Pediatr Crit Care Med2015; 16(3): 276–288.
4.
BarbaroRPPadenMLGunerYS, et al. Pediatric Extracorporeal Life Support Organization Registry international report 2016. ASAIO J2017; 63(4): 456–463.
5.
MeyerADRishmawiARKamuchekaR, et al. Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulation. J Thromb Haemost. Epub ahead of print November 2019. DOI: 10.1111/jth.14661.
6.
LanceMD.A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J2015; 13: 1.
7.
BartonRIgnjatovicVMonagleP.Anticoagulation during ECMO in neonatal and paediatric patients. Thromb Res2019; 173: 172–177.
8.
StockerCFHortonSB.Anticoagulation strategies and difficulties in neonatal and paediatric extracorporeal membrane oxygenation (ECMO). Perfusion2016; 31(2): 95–102.
9.
ColmanEYinEBLaineG, et al. Evaluation of a heparin monitoring protocol for extracorporeal membrane oxygenation and review of the literature. J Thorac Dis2019; 11(8): 3325–3335.
10.
NorthropMSSidonioRFPhillipsSE, et al. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life. Pediatr Crit Care Med2015; 16(1): 66–74.
11.
FanHZhuJH.A multifaceted anticoagulation strategy is needed for children supported with ECMO. J Intensive Care Med2018; 33(2): 142.
12.
BembeaMMAnnichGRycusP, et al. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med2013; 14(2): e77–e84.
13.
OliverWC.Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth2009; 13(3): 154–175.
14.
GuzzettaNAMonitzHGFernandezJD, et al. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass. Anesth Analg2010; 111(1): 173–179.
15.
NankervisCAPrestonTJDysartKC, et al. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation. ASAIO J2007; 53(1): 111–114.
16.
LiverisABelloRAFriedmannP, et al. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*. Pediatr Crit Care Med2014; 15(2): e72–e79.
17.
DavisMCAndersenNEJohanssonP, et al. Use of thromboelastograph and factor VII for the treatment of postoperative bleeding in a pediatric patient on ECMO after cardiac surgery. J Extra Corpor Technol2006; 38(2): 165–167.
18.
SpaldingGJHartrumpfMSierigT, et al. Cost reduction of perioperative coagulation management in cardiac surgery: value of “bedside” thrombelastography (ROTEM). Eur J Cardiothorac Surg2007; 31(6): 1052–1057.
19.
HendersonNSullivanJEMyersJ, et al. Use of thromboelastography to predict thrombotic complications in pediatric and neonatal extracorporeal membranous oxygenation. J Extra Corpor Technol2018; 50(3): 149–154.
20.
WhitingDDiNardoJA.TEG and ROTEM: technology and clinical applications. Am J Hematol2014; 89(2): 228–232.
21.
DiasJDHaneyEIMathewBA, et al. New-generation thromboelastography: comprehensive evaluation of citrated and heparinized blood sample storage effect on clot-forming variables. Arch Pathol Lab Med2017; 141(4): 569–577.
22.
VogelAMRadwanZACoxCSJr, et al. Admission rapid thrombelastography delivers real-time “actionable” data in pediatric trauma. J Pediatr Surg2013; 48(6): 1371–1376.
23.
MoynihanKJohnsonKStraneyL, et al. Coagulation monitoring correlation with heparin dose in pediatric extracorporeal life support. Perfusion2017; 32(8): 675–685.
24.
ChuDCAbu-SamraAGBairdGL, et al. Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation. Intensive Care Med2015; 41(2): 369–370.
25.
NguyenTMusickMTeruyaJ.Anticoagulation monitoring during extracorporeal membrane oxygenation: is anti-factor Xa assay (heparin level) a better test?*. Pediatr Crit Care Med2014; 15(2): 178–179.
26.
AnnichGAdachiI.Anticoagulation for pediatric mechanical circulatory support. Pediatr Crit Care Med2013; 14(5Suppl 1): S37–S42.
27.
MoganasundramSHuntBJSykesK, et al. The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children. Anesth Analg2010; 110(4): 995–1002.
28.
OrtmannERubinoAAltemimiB, et al. Validation of viscoelastic coagulation tests during cardiopulmonary bypass. J Thromb Haemost2015; 13(7): 1207–1216.
29.
HuangCYChenIMHsiehYC, et al. Thrombelastography change after bridging to left ventricular assist device from extracorporeal membrane oxygenation patients. J Chin Med Assoc2012; 75(8): 363–369.
30.
KrzanickiDSugavanamAMallettS.Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography. Liver Transpl2013; 19(8): 852–861.
31.
SunWJeleniowskiKZhaoX, et al. Thromboelastography (TEG)-based algorithm reduces blood product utilization in patients undergoing VAD implant. J Card Surg2014; 29(2): 238–243.
32.
BhatiaAKYabrodiMCarrollM, et al. Utility and correlation of known anticoagulation parameters in the management of pediatric ventricular assist devices. World J Cardiol2017; 9(9): 749–756.
33.
PanigadaMIapichinoGEBrioniM, et al. Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study. Ann Intensive Care2018; 8(1): 7.
34.
PekelharingJFurckABanyaW, et al. Comparison between thromboelastography and conventional coagulation tests after cardiopulmonary bypass surgery in the paediatric intensive care unit. Int J Lab Hematol2014; 36(4): 465–471.
35.
AlexanderDCButtWWBestJD, et al. Correlation of thromboelastography with standard tests of anticoagulation in paediatric patients receiving extracorporeal life support. Thromb Res2010; 125(5): 387–392.
36.
O’HalloranCPThiagarajanRRYarlagaddaVV, et al. Outcomes of infants supported with extracorporeal membrane oxygenation using centrifugal versus roller pumps: an analysis from the Extracorporeal Life Support Organization Registry. Pediatr Crit Care Med2019; 20(12): 1177–1184.
